Advances in imaging of colorectal cancer

Critical Reviews in Oncology/Hematology

Volumn 30, Issue 3, 1999, Pages 189-199

  Padhani, Anwar R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE; INDIUM; IODINE 123; IODINE 131; MANGAFODIPIR; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; SUPERPARAMAGNETIC IRON OXIDE; TECHNETIUM 99M;

CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; IMMUNOSCINTIGRAPHY; LYMPHADENOPATHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOIMMUNOASSAY; REVIEW; TUMOR RECURRENCE; ULTRASOUND;

EID: 0033012729     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(98)00048-1     Document Type: Article

References (65)

1. CRC Factsheet. Cancer of the large bowel-UK. Cancer Research Campaign Factsheet 18.1, 1993.
2. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. Cancer J Clin. 46:1996;5-27.
3. Freeny P.C., Marks W.M., Ryan J.A. et al. Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology. 158:1986;347-353.
4. Balthazar E.J., Megibow A.J., Hulnick D. et al. Carcinoma of the colon: detection and preoperative staging by CT. Am. J. Roentgenol. 150:1988;301-306.
5. Shank B., Dershaw D.D., Caravelli J. et al. A prospective study of the accuracy of preoperative computed tomographic staging of patients with biopsy proven rectal carcinoma. Dis. Colon Rectum. 33:1990;285-290.
6. Zerhouni E.A., Rutter C., Hamilton S.R. et al. CT and MR imaging in the staging of colorectal carcinoma: report of Radiology Diagnostic Oncology Group II. Radiology. 200:1996;443-451.
7. Heiken J.P., Weyman P.J., Lee J.K. et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography and MR imaging. Radiology. 171:1989;47-51.
8. Wernecke K., Rummeny E., Bongartz G. et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. Am. J. Roentgenol. 157:1991;731-739.
9. Matsui O., Takashima T., Kadoya M. et al. Liver metastases from colorectal cancers: detection with CT during arterial portography. Radiology. 165:1987;65-69.
10. Soyer P., Levesque M., Elias D. et al. Detection of liver metastasis from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology. 183:1992;541-544.
11. Kuszyk B.S., Bluemke D.A., Urban B.A. et al. Portal-phase contrast enhanced helical CT for the detection of malignant hepatic tumours: sensitivity based on comparison with intraoperative and pathologic findings. Am. J. Roentgenol. 166:1996;91-95.
12. Soyer P., Bluemke D.A., Hruban R.H. et al. Hepatic metastasis from colorectal cancer: detection and false positive findings with helical CT during arterial portography. Radiology. 193:1994;71-74.
13. Nelson R.C., Chezmar J.L., Sugarbaker P.H. et al. Hepatic tumours: comparison of CT during arterial portography, delayed CT, and MR imaging for pre-operative evaluation. Radiology. 172:1989;27-34.
14. Soyer P., Lacheheb D., Levesque M. False positive CT portography: correlation with pathologic findings. Am. J. Roentgenol. 160:1993;285-289.
15. Vining D.J. Virtual endoscopy: is it reality? Radiology. 200:1996;30-31.
16. Rubin G.R., Beaulieu C.F., Argiro V. et al. Perspective volume rendering of CT and MR images: applications for endoscopic imaging. Radiology. 199:1996;321-330.
17. Chan T.W., Kressel H.Y., Milestone B. et al. Rectal carcinoma: staging at MR imaging with endorectal surface coil. Work in progress. Radiology. 181:1991;461-467.
18. Okizuka H., Sugimura K., Ishida T. Preoperative local staging of rectal carcinoma with MR imaging and a rectal balloon. J. Magn. Reson. Imaging. 3:1993;329-335.
19. Schnall M.D., Furth E.E., Rosato E.F. et al. Rectal tumour stage: correlation of endorectal MR imaging and pathological findings. Radiology. 190:1994;709-714.
20. Hulsmans F.J.M., Tio T.L., Fockens P. et al. Assessment of tumour infiltration depth in rectal cancer with transrectal sonography: caution is necessary. Radiology. 190:1994;715-720.
21. Wang K.Y., Kimmey M.B., Nyberg D.A. et al. Colorectal neoplasms: accuracy of US in demonstrating the depth of invasion. Radiology. 165:1987;827-829.
22. deLange E.E. Staging rectal carcinoma with endorectal imaging: how much detail do we really need? Radiology. 190:1994;633-635.
23. Hagspiel K.D., Neidl K.F., Eichenberger A.C. et al. Detection of liver metastases: comparison of superparamagnetic iron oxide enhanced and unenhanced MR imaging at 1.5T with dynamic CT, intraoperative US and percutaneous US. Radiology. 196:1995;471-478.
24. Seneterre E., Taourel P., Bouvier G. et al. Detection of hepatic metastasis: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology. 200:1996;785-792.
25. Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology. 193:1994;593-595.
26. Soyer P. Will ferumoxides-enhanced MR imaging replace CT during arterial portography in the detection of hepatic metastases? Prologue to a promising future. Radiology. 20:1996;610-611.
27. Rinck P.A., Muller R.N. Magnetic resonance imaging contrast agents. Rinck P.A. The Rational Use of Magnetic Resonance Imaging. 1995;287-306 Blackwell, Oxford.
28. Thompson W.M., Trenkner S.W. Staging colorectal carcinoma. Radiol. Clin. North Am. 32:1994;25-37.
29. Sugimura K., Carrington B.M., Quivey J.M. et al. Post-irradiation changes in the pelvis: assessment with MR imaging. Radiology. 175:1990;805-813.
30. Moss A.A. Computed tomography in the staging of gastrointestinal carcinoma. Radiol. Clin. North Am. 20:1982;761-780.
31. Thoeni R.F. Colorectal cancer: cross-sectional imaging for staging of primary tumour and detection of local recurrence. Am. J. Roentgenol. 156:1991;909-915.
32. Ebner F., Kressel H.Y., Mintz M.C. et al. Tumour recurrence versus fibrosis in the female pelvis: differentiation with MR imaging at 1.5 T. Radiology. 166:1988;333-340.
33. Rafto S.E., Amendola M.A., Gefter W.B. MR imaging of recurrent colorectal carcinoma versus fibrosis. J. Comput. Assist. Tomogr. 12:1988;521-523.
34. Kinkel K., Tardivon A.A., Soyer P. et al. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Radiology. 200:1996;453-458.
35. Muller-Schimpfle M., Brix G., Layer G. et al. Recurrent rectal cancer: diagnosis with dynamic MR imaging. Radiology. 189:1993;881-889.
36. Glaser F., Schlag P., Herfarth C. Endorectal ultrasonography for the assessment of invasion of rectal tumours and lymph node involvement. Br. J. Surg. 77:1990;883-887.
37. Katsura Y., Yamada K., Ishizawa T. et al. Endorectal ultrasonography for the assessment of wall invasion and lymph node metastasis in rectal cancer. Dis. Colon Rectum. 35:1992;362-368.
38. Herzog U., von Flue M., Tondelli P. et al. How accurate is endorectal ultrasound in preoperative staging of rectal cancer? Dis. Colon Rectum. 36:1993;127-134.
39. Reading C.C. Endorectal sonography. Crit. Rev. Diag. Imag. 33:1992;1-28.
40. Beynon J., Mortensen N.J., Channer J.L. et al. Preoperative assessment of mesorectal lymph node involvement in rectal cancer. Br. J. Surg. 76:1989;276-279.
41. Rafaelsen S.R., Kronborg O., Larsen C. et al. Intraoperative ultrasonography in detection of hepatic metastases from colorectal cancer. Dis. Colon Rectum. 38:1995;355-360.
42. Meijer S., Paul M.A., Cuesta M.A. et al. Intra-operative ultrasound in detection of liver metastases. Eur. J. Cancer. 31:1995;1210-1211.
43. Clarke M.P., Kane R.A., Steele G. Jr et al. Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumours. Surgery. 106:1989;849-855.
44. Leen E., Angerson W.J., Wotherspoon H. et al. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and doppler perfusion index and evaluation of postoperative follow-up results. Radiology. 195:1995;113-116.
45. Leen E., Angerson W.G., Cooke T.G. et al. Prognostic power of doppler perfusion index in colorectal cancer. Ann. Surg. 223:1996;199-203.
46. Shuman W.P. Liver metastases from colorectal carcinoma: detection with doppler US-guided measurements of liver blood flow-past, present, future. Radiology. 195:1995;9-10.
47. Warren H.W., Angerson W.J., Leen E. et al. Haemodynamic changes associated with colorectal liver metastases: evidence of a humoural mediator. Br. J. Surg. 80:1991;1461.
48. Leveson S.H., Wiggins P.A., Giles G.R. et al. Deranged liver blood flow patterns in the detection of liver metastases. Br. J. Surg. 72:1985;128-130.
49. Ryan J.W. Immunoscintigraphy in primary colorectal cancer. Cancer. 71:1993;4217-4224.
50. Abdel-Nabi H., Doerr R.J. Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: current status and future perspectives. Am. J. Surg. 163:1992;448-456.
51. Abdel-Nabi H., Doerr R.J. Clinical applications of indium-111-labelled monoclonal antibody imaging in colorectal cancer patients. Semin. Nucl. Med. 23:1993;99-113.
52. Tempero M., Brand R., Holdeman K. et al. New imaging techniques in colorectal cancer. Semin. Oncol. 22:1995;448-471.
53. Doerr R.J., Abdel-Nabi H., Krag D. et al. Radiolabeled antibody imaging in the management of colorectal cancer: results of a multicenter clinical study. Ann. Surg. 214:1991;118-124.
54. Gasparini M., Buraggi G.L., Regalia E. et al. Comparison of radioimmunodetection with other imaging methods in evaluation of local relapses of colorectal cancer. Cancer. 73:1994;846-849.
55. Moffat F.L., Vargas-Cuba R.D., Serafini A.N. et al. Radioimmunodetection of colorectal carcinoma using technetium-99m-labelled Fab' fragments of IMMU-4 anti-carcinoembryonic antigen monoclonal antibody. Cancer. 73:1994;836-845.
56. Abdel-Nabi H.H., Chan H.W., Doerr R.J. Indium-labelled anti-colorectal carcinoma monoclonal antibody accumulation in non-tumour tissue in patients with colorectal carcinoma. J. Nucl. Med. 31:1990;1975-1979.
57. Strauss L.G., Conti P.S. The applications of PET in clinical oncology. J. Nucl. Med. 32:1991;623-648.
58. Falk P.M., Gupta N.C., Thorson A.G. et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis. Colon Rectum. 37:1994;153-156.
59. Gupta N., Brafield H. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin. Nucl. Med. 26:1996;65-73.
60. Ito K., Kato T., Tadokoro M. et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology. 182:1992;549-552.
61. Schiepers C., Penninckx F., De Vadder N. et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur. J. Surg. Oncol. 21:1995;517-522.
62. Grabbe E., Winkler R. Local recurrence after sphincter saving resection for rectal and rectosigmoid carcinoma: value of various diagnostic methods. Radiology. 155:1985;305-310.
63. Pounds T.R., Valk P.E., Haseman M.K. et al. Whole-body PET-FDG imaging in diagnosis of recurrent colorectal cancer. J. Nucl. Med. 36:1995;57.
64. Haberkorn U., Strauss L., Dimitrakopoulou A. et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumours receiving radiotherapy. J. Nucl. Med. 32:1991;1485-1490.
65. Findlay M., Young H., Cunningham D. et al. Noninvasive monitoring of tumour metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer metastases: correlation with tumour response to fluorouracil. J. Clin. Oncol. 14:1996;691-696.